Dr. Balar Discusses the Impact of Immunotherapy on Bladder Cancer – OncLive
|
Dr. Balar Discusses the Impact of Immunotherapy on Bladder Cancer
OncLive Arjun V. Balar, MD, assistant professor, Department of Medicine, director, Genitourinary Medical Oncology Program, NYU Langone's Perlmutter Cancer Center, discusses the impact of immunotherapy on patients with bladder cancer. The introduction of … |
